Abstract
The Centers for Medicare and Medicaid Services (CMS) has recently proposed expanded coverage for implantable cardioverter defibrillators (ICD) in patients with left ventricular ejection fraction (LVEF) ≤ 30 percent with non ischemic cardiomyopathy (NICMP) ≥ 9 months. To investigate the ramifications of these criteria, the ICD registry from Tufts-New England Medical Center was analyzed for arrhythmic events and death in patients with newly diagnosed versus NICMP diagnosed ≥ 9 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
